Big Move For Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. (HOTH:NASDAQ) rocketted at $4.4, representing a gain of 44.7%. On Wed, Dec 28, 2022, HOTH:NASDAQ hit a New 2-Week High of $4.4. The stock appeared on our News Catalysts scanner on Thu, Dec 01, 2022 at 11:32 AM in the 'INVESTOR UPDATE' category. From Wed, Dec 14, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days

The stock spiked on Fri, Dec 16, 2022 at $5.48 with a volume of 1M+.

About Hoth Therapeutics, Inc. (HOTH:NASDAQ)

Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.